Previous Close | 69.46 |
1-Year Change | -26.23% |
6-Months Change | -47.59% |
3-Months Change | -40.16% |
Moving Avg (50d) | 80.704 |
Moving Avg (200d) | 113.767 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 26.8B |
Beta (3-Years) | 1.2 |
Revenue Growth (ttm) | 21.85% |
Net Profit Margin (ttm) | 11.08% |
Return On Assets (ttm) | 5.72% |
EPS (ttm) | 0.91 |
PE Ratio (ttm) | 76.33 |
Dividend Yield | % |
Asset Description: | DexCom, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
68.071 | 65.987 | 64.598 | 62.514 | 59.041 | 55.568 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.